CIMIT Forum: Using Simulation to Enhance or Replace Clinical Trials for Medical Technologies

INTERACT

Related Forum Topics

Panel: Using Simulation to Enhance or Replace Clinical Trials for Medical Technologies

12.07.2010

PRESENTER:
Andrea Cassano-Piché, MASc, PEng, Human Factors Engineer, Health Technology Safety Research Team, University Health Network, Ontario

Howard L. Golub, MD, PHD, Principal, Care-Safe Inc.

Susan Gould, Senior Director, Clinical Development, Global Infusion Systems, Baxter Healthcare Corporation

Professor Alan Merry,
ONZM, FANZCA, FFPANZCA, FRCA, Hon FFFLM
Practitioner in Cardiac Anaesthesia and Chronic Pain Management, Auckland City Hospital; Head of the Department of Anaesthesiology, University of Auckland

Keith Isaacson, MD
Medical Director, Minimally Invasive Gynecological Surgery Unit, Newton-Wellesley Hospital; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Attending Physician, Brigham and Women's Hospital and Boston IVF; CIMIT Site Miner, Newton-Wellesley Hospital

MODERATOR:
Jeffrey B. Cooper, PhD, Founder and Executive Director, Center for Medical Simulation; Professor of Anaesthesia, Harvard Medical School, Department of Anesthesia and Critical Care, Massachusetts General Hospital

Forum Abstract

Simulation of healthcare clinical situations is now used widely for many training, safety and research applications. There are about 2,000 centers around the world using various forms of simulation, most including computer-controlled mannequins and other technologies with a range of capabilities and placed in medical environments that can be accurately representative of real clinical settings. In this session, we will learn about how simulation is being used for identifying human factors issues early on and thus likely shortening the device development cycle. We expect to imagine how clinical trials for different types of medical technologies can be further enhanced in the future, or for some things, perhaps eliminated. The two presenters will share their experiences and three panel reactors will respond with their views, experiences and comments.